Alumis readies IPO to fund rival drug to Bristol Myers’ Sotyktu

cafead

Administrator
Staff member
  • cafead   Jun 10, 2024 at 11:40: AM
via Biotechnology startup Alumis on Friday outlined plans for an initial public offering that would fund clinical development of a pair of autoimmune and neurological disease drugs.

article source
 

<